Results 131 to 140 of about 3,479,441 (357)

Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury [PDF]

, 2006
Ji Ma, Alec D. Weisberg, Jane P. Griffin, Douglas E. Vaughan, Agnes B. Fogo, Nancy J. Brown   +5 more
openalex   +1 more source

Continuity of care and risk of vision loss in patients with newly developed macular degeneration

Acta Ophthalmologica, EarlyView.
Abstract Purpose Neovascular age‐related macular degeneration (AMD) is a major cause of vision loss. Effective treatment requires sustained care, which may be influenced by continuity of care (COC). Understanding this association is crucial for improving patient outcomes.
In Hwan Cho, Minah Park, Dae Joong Ma, In Hwan Hong, Hyunkyu Kim, Seung Hoon Kim   +5 more
wiley   +1 more source

Plasma plasminogen levels in early respiratory distress syndrome

The Turkish Journal of Pediatrics, 1996
The serum plasminogen status in 35 preterm infants with or without respiratory distress syndrome (RDS) was determined in the first few hours of life.
M Yurdakök, S Yiğit, B Gürakan, S Dündar, S Kirazli   +4 more
doaj  

Antibodies Preventing the Interaction of Tissue-Type Plasminogen Activator With N-Methyl- d -Aspartate Receptors Reduce Stroke Damages and Extend the Therapeutic Window of Thrombolysis [PDF]

, 2011
Richard Macrez, Pauline Obiang, Maxime Gauberti, Benoit D. Roussel, Amandine Baron, Jérôme Parcq, Frédéric Cassé, Yannick Hommet, Cyrille Orset, Véronique Agin, Laurent Bezin, Teresa García‐Berrocoso, Karl Uwe Petersen, Joan Montaner, Eric Maubert, Denis Vivien, Carine Ali   +16 more
openalex   +1 more source

Interventions for submacular haemorrhage: A systematic review and network meta‐analysis of controversies—On behalf of the Spanish Vitreo‐Retinal Society (SERV)

Acta Ophthalmologica, EarlyView.
Abstract Purpose This systematic review aims to evaluate and synthesize the existing literature on the interventions used for submacular haemorrhage (SMH), highlighting the controversies and differences in clinical practice. Method A systematic review was conducted following the PRISMA guidelines.
Salvador Pastor‐Idoate, Pablo Redruello‐Guerrero, Laura de Juan Hernández, Gregorio Benites‐Narcizo, Mario Rivera‐Izquierdo, José García‐Arumí, José Carlos Pastor Jimeno   +6 more
wiley   +1 more source

Treatment With Tissue Plasminogen Activator in the Golden Hour and the Shape of the 4.5-Hour Time-Benefit Curve in the National United States Get With The Guidelines-Stroke Population

Circulation, 2017
J. Kim, G. Fonarow, Eric E. Smith, M. Reeves, Digvijaya Navalkele, J. Grotta, Maria V. Grau‐Sepulveda, Adrian F. Hernandez, E. Peterson, L. Schwamm, J. Saver   +10 more
semanticscholar   +1 more source

Plasminogen Activator Inhibitor 2 [PDF]

, 2020
National Cancer Institute
openalex   +1 more source

Real‐world outcomes of aflibercept 8 mg in patients previously treated for neovascular age‐related macular degeneration

Acta Ophthalmologica, EarlyView.
Abstract Purpose To evaluate visual, anatomical and safety outcomes of aflibercept 8 mg in previously treated patients with neovascular age‐related macular degeneration (nAMD). Methods This retrospective study included nAMD patients switched to aflibercept 8 mg from prior anti‐VEGF therapies at Sahlgrenska University Hospital between February 2024 and ...
Imadeddin Abu Ishkheidem, Esra Inci, Martin Breimer, Sofia Töyrä Silfverswärd, Madeleine Zetterberg, Marita Andersson Grönlund   +5 more
wiley   +1 more source

Effect of urokinase type plasminogen activator on in vitro bovine oocyte maturation [PDF]

, 2017
Mariela Roldán‐Olarte, V. Maillo, María Jesús Sánchez‐Calabuig, P. Beltrán-Breña, D. Rizos, Alfonso Gutiérrez‐Adán   +5 more
openalex   +1 more source

A high‐throughput bone marrow 3D co‐culture system to study resistance to BCR signalling targeted agents in B‐NHL

British Journal of Haematology, EarlyView.
Bone marrow (BM) involvement in B‐cell non‐Hodgkin lymphoma (B‐NHL) is associated with poor prognosis, as the BM microenvironment provides a protective niche that promotes therapeutic resistance. We developed a simplified, automated and high‐throughput 3D BM co‐culture model that faithfully reproduces key tumour–stroma interactions.
Alex Zadro, Alberto Arribas, Maria Vittoria Colombo, Eleonora Cannas, Filippo Spriano, Luciano Cascione, Afua Adjeiwaa Mensah, Federico Simonetta, Dalila Petta, Christian Candrian, Chiara Arrigoni, Francesco Bertoni, Matteo Moretti   +12 more
wiley   +1 more source